Colossal Biosciences and Anduril's Palmer Luckey back Warhound, a startup developing genetically engineered dogs for military work.
Warhound raised $200 million to develop gene-edited military dogs and build the kennels and training facilities needed to prepare them for service.
Warhound plans to use gene editing and cloning to produce healthier, more capable working dogs for the U.S. military, with the first puppies expected in 2027.
The company is a collab between defense tech firm Anduril and Colossal Biosciences, the biotech startup looking to bring back the woolly mammoth.
Warhound came out of stealth on Wednesday with $200 million in funding and a mission to create "elite working dogs" equipped with "advanced body armor."
Warhound, the brainchild of Ben Lamm and Palmer Luckey, emerges from stealth to genetically engineer dogs for military and law enforcement.
"A dog is the oldest autonomous system there is," Ben Lamm, the executive who figured out how to clone dire wolves, told Fortune.
First reported:
First saved on ClustZ:
Coverage updated:
We use cookies to improve your experience and analyze site traffic. By clicking "Accept", you agree to our use of cookies. See our Privacy Policy.